Bayer, J&J win third U.S. trial over Xarelto bleeding risk
August 18, 2017 at 17:33 PM EDT
Aug 18 (Reuters) - A federal jury has cleared Bayer AG and Johnson & Johnson of liability in the third case to go to trial out of thousands of lawsuits claiming the drugmakers' blood thinner Xarelto led to severe internal bleeding.
